Timber Pharmaceuticals Inc (TMBR) Stock Declines -42.75% This Week; Should You Buy?

Friday, November 17, 2023 10:58 AM | InvestorsObserver Analysts

Mentioned in this article

Timber Pharmaceuticals Inc (TMBR) Stock Declines -42.75% This Week; Should You Buy?

Timber Pharmaceuticals Inc (TMBR) stock is lower by -10.43% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives TMBR stock a score of 26 out of a possible 100.

That rank is influenced by a short-term technical score of 8. TMBR's rank also includes a long-term technical score of 68.

TMBR has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on TMBR!

See Full TMBR Report

What's Happening with TMBR Stock Today

Timber Pharmaceuticals Inc (TMBR) stock has risen 16.8% while the S&P 500 is lower by 0% as of 10:58 AM on Friday, Nov 17. TMBR has gained $0.21 from the previous closing price of $1.25 on volume of 147,093 shares. Over the past year the S&P 500 is up 14.23% while TMBR is lower by -10.43%. TMBR lost -$5.88 per share in the over the last 12 months. Click Here to get the full Stock Report for Timber Pharmaceuticals Inc stock.